Basic Information
| RNALocate ID: | RLID:11001928 |
| RNA Symbol: | hsa-miR-150-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-150 |
| RNA ID: | miRBase:MIMAT0000451 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 25135963 |
| Tissue/Cell Line: | Serum |
| Method: | Next-generation RNA sequencing |
| Description: | When summarizing total counts per sample type, we calculated mean raw counts per RNA-Seq library and then ranked them from high to low for miRNA, mRNA, ncRNA and tRNA categories. The top 12 are listed in table 1. Data are collected from Table 1: RNA representation in serum- and urine-derived exosomes: top 12 RNA transcripts organized by RNA type. Values represent mean counts of mapped reads to reference transcripts. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001836 | Lysosome | HeLa cells|MCF-7 cells | 29784380 |
| RLID:01001837 | Mitochondrion | Human cervical cancer cell line (HeLa)|Breast cancer cell line (MCF-7) | 29784380 |
| RLID:11001921 | Exosome | Peripheral blood | 31746410 |
| RLID:11001922 | Exosome | Primary ovarian tumor cells|Serum | 18589210 |
| RLID:11001923 | Exosome | Saliva | 19627513 |
| RLID:11001924 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001925 | Exosome | Breast milk | 22211110 |
| RLID:11001926 | Exosome | Brain tissue | 23382797 |
| RLID:11001927 | Exosome | Plasma | 23663360 |
| RLID:11001929 | Extracellular Vesicle | Plasma | 28588009 |
| RLID:11001930 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001931 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000099 | Exosome | Blood|B lymphoblastoid cells|Colon tissue|Endothelial cells|Lymphoma tissue|Mast cells | |
| RLID-D:11000379 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-150-5p | Diffuse large b cell lymphoma | MNDR-E-MI-16569 |
| MNDR | hsa-miR-150-5p | Splenic marginal zone lymphoma | MNDR-E-MI-16570 |
| MNDR | hsa-miR-150-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-16571 |
| MNDR | hsa-miR-150-5p | Large cell neuroendocrine cancer | MNDR-E-MI-16572 |
| MNDR | hsa-miR-150-5p | Medulloblastoma | MNDR-E-MI-16573 |
| MNDR | hsa-miR-150-5p | B cell lymphoma of malt type | MNDR-E-MI-16574 |
| MNDR | hsa-miR-150-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-16575 |
| MNDR | hsa-miR-150-5p | Lymphoma | MNDR-E-MI-16576 |
| MNDR | hsa-miR-150-5p | Lymphoma non-hodgkin | MNDR-E-MI-16577 |
| MNDR | hsa-miR-150-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-16578 |
| MNDR | hsa-miR-150-5p | Her2-receptor positive breast cancer | MNDR-E-MI-16579 |
| MNDR | hsa-miR-150-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-16580 |
| MNDR | hsa-miR-150-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-16581 |
| MNDR | hsa-miR-150-5p | Small intestine cancer | MNDR-E-MI-16582 |
| MNDR | hsa-miR-150-5p | Prostate cancer | MNDR-E-MI-16583 |
| MNDR | hsa-miR-150-5p | Chronic lymphocytic leukemia | MNDR-E-MI-16584 |
| MNDR | hsa-miR-150-5p | Gastric cancer | MNDR-E-MI-16585 |
| MNDR | hsa-miR-150-5p | Gastric lymphoma | MNDR-E-MI-16586 |
| MNDR | hsa-miR-150-5p | Alzheimer disease | MNDR-E-MI-16587 |
| MNDR | hsa-miR-150-5p | Intracranial aneurysm | MNDR-E-MI-16588 |
| MNDR | hsa-miR-150-5p | Osteoporosis | MNDR-E-MI-16589 |
| MNDR | hsa-miR-150-5p | Dysautonomia familial | MNDR-E-MI-16590 |
| MNDR | hsa-miR-150-5p | Head and neck cancer | MNDR-E-MI-16591 |
| MNDR | hsa-miR-150-5p | Primary biliary cirrhosis | MNDR-E-MI-16592 |
| MNDR | hsa-miR-150-5p | Leukemia | MNDR-E-MI-16593 |
| MNDR | hsa-miR-150-5p | Huntington disease | MNDR-E-MI-16594 |
| MNDR | hsa-miR-150-5p | Chorea | MNDR-E-MI-16595 |
| MNDR | hsa-miR-150-5p | Cardiovascular disease | MNDR-E-MI-16596 |
| MNDR | hsa-miR-150-5p | Uterine fibroid | MNDR-E-MI-16597 |
| MNDR | hsa-miR-150-5p | Lung cancer | MNDR-E-MI-16598 |
| MNDR | hsa-miR-150-5p | Giant cell arteritis | MNDR-E-MI-16599 |
| MNDR | hsa-miR-150-5p | Kawasaki disease | MNDR-E-MI-16600 |
| MNDR | hsa-miR-150-5p | Down syndrome | MNDR-E-MI-16601 |
| MNDR | hsa-miR-150-5p | Parkinson disease | MNDR-E-MI-16602 |
| MNDR | hsa-miR-150-5p | Basal-like breast cancer | MNDR-E-MI-16603 |
| MNDR | hsa-miR-150-5p | Squamous cell carcinoma | MNDR-E-MI-16604 |
| MNDR | hsa-miR-150-5p | Thyroid cancer | MNDR-E-MI-16605 |
| MNDR | hsa-miR-150-5p | Pituitary neoplasms | MNDR-E-MI-16606 |
| MNDR | hsa-miR-150-5p | Pancreatic cancer | MNDR-E-MI-16607 |
| MNDR | hsa-miR-150-5p | Melanoma | MNDR-E-MI-16608 |
| MNDR | hsa-miR-150-5p | Rectum adenocarcinoma | MNDR-E-MI-16609 |
| MNDR | hsa-miR-150-5p | Nephroblastoma | MNDR-E-MI-16610 |
| MNDR | hsa-miR-150-5p | Colon cancer | MNDR-E-MI-16611 |
| MNDR | hsa-miR-150-5p | Colon adenocarcinoma | MNDR-E-MI-16612 |
| MNDR | hsa-miR-150-5p | Multiple sclerosis | MNDR-E-MI-16613 |
| MNDR | hsa-miR-150-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-16614 |
| MNDR | hsa-miR-150-5p | Familial ovarian cancer | MNDR-E-MI-16615 |
| MNDR | hsa-miR-150-5p | Kidney cancer | MNDR-E-MI-16616 |
| MNDR | hsa-miR-150-5p | Carcinoma ductal breast | MNDR-E-MI-16617 |
| MNDR | hsa-miR-150-5p | Glioblastoma | MNDR-E-MI-16618 |
| MNDR | hsa-miR-150-5p | Glioma | MNDR-E-MI-16619 |
| MNDR | hsa-miR-150-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-16620 |
| MNDR | hsa-miR-150-5p | Osteosarcoma | MNDR-E-MI-16621 |
| MNDR | hsa-miR-150-5p | Inclusion body myositis | MNDR-E-MI-16622 |
| MNDR | hsa-miR-150-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-16623 |
| MNDR | hsa-miR-150-5p | Liver cancer | MNDR-E-MI-16624 |
| MNDR | hsa-miR-150-5p | Uterine cancer | MNDR-E-MI-16625 |
| MNDR | hsa-miR-150-5p | Gastric adenocarcinoma | MNDR-E-MI-16626 |
| MNDR | hsa-miR-150-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-16627 |
| MNDR | hsa-miR-150-5p | Lung squamous cell carcinoma | MNDR-E-MI-16628 |
| MNDR | hsa-miR-150-5p | Non-small cell lung cancer | MNDR-E-MI-16629 |
| MNDR | hsa-miR-150-5p | Lung adenocarcinoma | MNDR-E-MI-16630 |
| MNDR | hsa-miR-150-5p | Adrenocortical carcinoma | MNDR-E-MI-16631 |
| MNDR | hsa-miR-150-5p | Thyroid carcinoma | MNDR-E-MI-16632 |
| MNDR | hsa-miR-150-5p | Papillary thyroid carcinoma | MNDR-E-MI-16633 |
| MNDR | hsa-miR-150-5p | Bladder urothelial carcinoma | MNDR-E-MI-16634 |
| MNDR | hsa-miR-150-5p | Pancreatic adenocarcinoma | MNDR-E-MI-16635 |
| MNDR | hsa-miR-150-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-16636 |
| MNDR | hsa-miR-150-5p | Carcinoma renal cell | MNDR-E-MI-16637 |
| MNDR | hsa-miR-150-5p | Papillary renal cell carcinoma | MNDR-E-MI-16638 |
| MNDR | hsa-miR-150-5p | Renal clear cell carcinoma | MNDR-E-MI-16639 |
| MNDR | hsa-miR-150-5p | Biliary tract cancer | MNDR-E-MI-16640 |
| MNDR | hsa-miR-150-5p | Cholangiocarcinoma | MNDR-E-MI-16641 |
| MNDR | hsa-miR-150-5p | Pancreatitis | MNDR-E-MI-16642 |
| MNDR | hsa-miR-150-5p | Esophageal cancer | MNDR-E-MI-16643 |
| MNDR | hsa-miR-150-5p | HIV | MNDR-E-MI-16644 |
| MNDR | hsa-miR-150-5p | Lung small cell carcinoma | MNDR-E-MI-16645 |
| MNDR | hsa-miR-150-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-16646 |
| MNDR | hsa-miR-150-5p | Testicular germ cell cancer | MNDR-E-MI-16647 |
| MNDR | hsa-miR-150-5p | T acute lymphoblastic leukemia | MNDR-E-MI-16648 |
| MNDR | hsa-miR-150-5p | Acute t cell leukemia | MNDR-E-MI-16649 |
| MNDR | hsa-miR-150-5p | Heart failure | MNDR-E-MI-16650 |
| MNDR | hsa-miR-150-5p | Adenoma | MNDR-E-MI-16651 |
| MNDR | hsa-miR-150-5p | Breast invasive carcinoma | MNDR-E-MI-16652 |
| MNDR | hsa-miR-150-5p | Early hepatocellular carcinoma | MNDR-E-MI-16653 |
| MNDR | hsa-miR-150-5p | Familiar ovarian carcinoma | MNDR-E-MI-16654 |
| MNDR | hsa-miR-150-5p | B-cell lymphoma | MNDR-E-MI-16655 |
| MNDR | hsa-miR-150-5p | Rheumatoid arthritis | MNDR-E-MI-16656 |
| MNDR | hsa-miR-150-5p | T-cell leukemia | MNDR-E-MI-16657 |
| MNDR | hsa-miR-150-5p | Retinoblastoma | MNDR-E-MI-16658 |
| MNDR | hsa-miR-150-5p | Neuroblastoma | MNDR-E-MI-16659 |
| MNDR | hsa-miR-150-5p | Periodontitis | MNDR-E-MI-16660 |
| MNDR | hsa-miR-150-5p | Hodgkin lymphoma | MNDR-E-MI-16661 |
| MNDR | hsa-miR-150-5p | Burkitt lymphoma | MNDR-E-MI-16662 |
| MNDR | hsa-miR-150-5p | Skin cutaneous melanoma | MNDR-E-MI-16663 |
| MNDR | hsa-miR-150-5p | Skin melanoma | MNDR-E-MI-16664 |
| MNDR | hsa-miR-150-5p | Systemic lupus erythematosus | MNDR-E-MI-16665 |
| MNDR | hsa-miR-150-5p | Acute myelogenous leukemia | MNDR-E-MI-16666 |
| MNDR | hsa-miR-150-5p | Colorectal cancer | MNDR-E-MI-16667 |
| MNDR | hsa-miR-150-5p | Nasopharynx carcinoma | MNDR-E-MI-16668 |
| MNDR | hsa-miR-150-5p | Acute myocardial infarction | MNDR-E-MI-16669 |
| MNDR | hsa-miR-150-5p | Multiple myeloma | MNDR-E-MI-16670 |
| MNDR | hsa-miR-150-5p | Ovarian epithelial cancer | MNDR-E-MI-16671 |
| MNDR | hsa-miR-150-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-16672 |
| MNDR | hsa-miR-150-5p | Ependymoma | MNDR-E-MI-16673 |
| MNDR | hsa-miR-150-5p | Cardiomegaly | MNDR-E-MI-16674 |
| MNDR | hsa-miR-150-5p | Infection | MNDR-E-MI-16675 |
| MNDR | hsa-miR-150-5p | Nasopharyngeal cancer | MNDR-E-MI-16676 |
| MNDR | hsa-miR-150-5p | Sleep deprivation | MNDR-E-MI-16677 |
| MNDR | hsa-miR-150-5p | Wounds and injuries | MNDR-E-MI-16678 |
| MNDR | hsa-miR-150-5p | Epstein-barr virus infections | MNDR-E-MI-16679 |
| MNDR | hsa-miR-150-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-16680 |
| MNDR | hsa-miR-150-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-16681 |
| MNDR | hsa-miR-150-5p | Pituitary acth hypersecretion | MNDR-E-MI-16682 |
| MNDR | hsa-miR-150-5p | Stroke lacunar | MNDR-E-MI-16683 |
| MNDR | hsa-miR-150-5p | Duke A | MNDR-E-MI-16684 |
| MNDR | hsa-miR-150-5p | Tubulovillous adenoma | MNDR-E-MI-16685 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADIPOR2 | Homo sapiens | RR00047795 |
TOP